![]() |
||||||
|
![]() | Fusion Gene Summary |
![]() | Fusion Gene ORF analysis |
![]() | Fusion Genomic Features |
![]() | Fusion Protein Features |
![]() | Fusion Gene Sequence |
![]() | Fusion Gene PPI analysis |
![]() | Related Drugs |
![]() | Related Diseases |
Fusion gene:CHRNB2-SEC1P (FusionGDB2 ID:HG1141TG653677) |
Fusion Gene Summary for CHRNB2-SEC1P |
![]() |
Fusion gene information | Fusion gene name: CHRNB2-SEC1P | Fusion gene ID: hg1141tg653677 | Hgene | Tgene | Gene symbol | CHRNB2 | SEC1P | Gene ID | 1141 | 653677 |
Gene name | cholinergic receptor nicotinic beta 2 subunit | ||
Synonyms | EFNL3|nAChRB2 | ||
Cytomap | ('CHRNB2')('SEC1P') 1q21.3 | ||
Type of gene | protein-coding | ||
Description | neuronal acetylcholine receptor subunit beta-2acetylcholine receptor, nicotinic, beta 2 (neuronal)beta2 human neuronal nicotinic acetylcholine receptorcholinergic receptor, nicotinic beta 2cholinergic receptor, nicotinic, beta 2 (neuronal)cholinergic | ||
Modification date | 20200313 | ||
UniProtAcc | P17787 | . | |
Ensembl transtripts involved in fusion gene | ENST00000368476, | ||
Fusion gene scores | * DoF score | 3 X 3 X 1=9 | 4 X 4 X 2=32 |
# samples | 3 | 4 | |
** MAII score | log2(3/9*10)=1.73696559416621 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(4/32*10)=0.321928094887362 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: CHRNB2 [Title/Abstract] AND SEC1P [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | CHRNB2(154552109)-SEC1P(49143438), # samples:2 | ||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | CHRNB2 | GO:0001666 | response to hypoxia | 12189247 |
Hgene | CHRNB2 | GO:0007165 | signal transduction | 8906617 |
Hgene | CHRNB2 | GO:0035094 | response to nicotine | 12189247 |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
Top |
Fusion Gene ORF analysis for CHRNB2-SEC1P |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
Top |
Fusion Genomic Features for CHRNB2-SEC1P |
![]() |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Top |
Fusion Protein Features for CHRNB2-SEC1P |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/:154552109/:49143438) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
CHRNB2 | . |
FUNCTION: After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane permeable to sodiun ions. {ECO:0000269|PubMed:22361591}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for CHRNB2-SEC1P |
![]() |
Top |
Fusion Gene PPI Analysis for CHRNB2-SEC1P |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for CHRNB2-SEC1P |
![]() (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Hgene | CHRNB2 | P17787 | DB00184 | Nicotine | Agonist | Small molecule | Approved |
Hgene | CHRNB2 | P17787 | DB00333 | Methadone | Antagonist | Small molecule | Approved |
Hgene | CHRNB2 | P17787 | DB00514 | Dextromethorphan | Antagonist | Small molecule | Approved |
Hgene | CHRNB2 | P17787 | DB00898 | Ethanol | Small molecule | Approved | |
Hgene | CHRNB2 | P17787 | DB01245 | Decamethonium | Small molecule | Approved | |
Hgene | CHRNB2 | P17787 | DB00657 | Mecamylamine | Small molecule | Approved|Investigational | |
Hgene | CHRNB2 | P17787 | DB00747 | Scopolamine | Small molecule | Approved|Investigational | |
Hgene | CHRNB2 | P17787 | DB00981 | Physostigmine | Small molecule | Approved|Investigational | |
Hgene | CHRNB2 | P17787 | DB01273 | Varenicline | Partial agonist | Small molecule | Approved|Investigational |
Hgene | CHRNB2 | P17787 | DB00572 | Atropine | Small molecule | Approved|Vet_approved | |
Hgene | CHRNB2 | P17787 | DB00753 | Isoflurane | Antagonist | Small molecule | Approved|Vet_approved |
Top |
Related Diseases for CHRNB2-SEC1P |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | CHRNB2 | C1854335 | Epilepsy, Nocturnal Frontal Lobe, Type 3 | 3 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
Hgene | CHRNB2 | C0036341 | Schizophrenia | 2 | PSYGENET |
Hgene | CHRNB2 | C0002395 | Alzheimer's Disease | 1 | CTD_human |
Hgene | CHRNB2 | C0003469 | Anxiety Disorders | 1 | CTD_human |
Hgene | CHRNB2 | C0004352 | Autistic Disorder | 1 | CTD_human |
Hgene | CHRNB2 | C0011265 | Presenile dementia | 1 | CTD_human |
Hgene | CHRNB2 | C0020672 | Hypothermia, natural | 1 | CTD_human |
Hgene | CHRNB2 | C0021368 | Inflammation | 1 | CTD_human |
Hgene | CHRNB2 | C0027746 | Nerve Degeneration | 1 | CTD_human |
Hgene | CHRNB2 | C0034933 | Reflex, Abnormal | 1 | CTD_human |
Hgene | CHRNB2 | C0038587 | Substance Withdrawal Syndrome | 1 | CTD_human |
Hgene | CHRNB2 | C0038644 | Sudden infant death syndrome | 1 | CTD_human |
Hgene | CHRNB2 | C0041671 | Attention Deficit Disorder | 1 | CTD_human |
Hgene | CHRNB2 | C0085541 | Epilepsy, Frontal Lobe | 1 | CTD_human |
Hgene | CHRNB2 | C0086189 | Drug Withdrawal Symptoms | 1 | CTD_human |
Hgene | CHRNB2 | C0087169 | Withdrawal Symptoms | 1 | CTD_human |
Hgene | CHRNB2 | C0151572 | Reflex, Corneal, Decreased | 1 | CTD_human |
Hgene | CHRNB2 | C0151888 | Hyporeflexia | 1 | CTD_human |
Hgene | CHRNB2 | C0151889 | Hyperreflexia | 1 | CTD_human |
Hgene | CHRNB2 | C0234146 | Absent reflex | 1 | CTD_human |
Hgene | CHRNB2 | C0234784 | Reflex, Gag, Absent | 1 | CTD_human |
Hgene | CHRNB2 | C0241772 | Reflex, Deep Tendon, Absent | 1 | CTD_human |
Hgene | CHRNB2 | C0276496 | Familial Alzheimer Disease (FAD) | 1 | CTD_human |
Hgene | CHRNB2 | C0277839 | Hoffman's Reflex | 1 | CTD_human |
Hgene | CHRNB2 | C0277850 | Reflex, Pendular | 1 | CTD_human |
Hgene | CHRNB2 | C0278211 | Reflex, Corneal, Absent | 1 | CTD_human |
Hgene | CHRNB2 | C0376280 | Anxiety States, Neurotic | 1 | CTD_human |
Hgene | CHRNB2 | C0393671 | Frontal Epilepsy, Benign, Childhood | 1 | CTD_human |
Hgene | CHRNB2 | C0393683 | Epilepsy, Supplementary Motor | 1 | CTD_human |
Hgene | CHRNB2 | C0393684 | Epilepsy, Cingulate | 1 | CTD_human |
Hgene | CHRNB2 | C0393688 | Epilepsy, Opercular | 1 | CTD_human |
Hgene | CHRNB2 | C0494463 | Alzheimer Disease, Late Onset | 1 | CTD_human |
Hgene | CHRNB2 | C0522345 | Reflex, Acoustic, Abnormal | 1 | CTD_human |
Hgene | CHRNB2 | C0546126 | Acute Confusional Senile Dementia | 1 | CTD_human |
Hgene | CHRNB2 | C0558845 | Reflex, Ankle, Absent | 1 | CTD_human |
Hgene | CHRNB2 | C0558846 | Reflex, Triceps, Absent | 1 | CTD_human |
Hgene | CHRNB2 | C0558847 | Reflex, Biceps, Absent | 1 | CTD_human |
Hgene | CHRNB2 | C0576612 | Reflex, Anal, Absent | 1 | CTD_human |
Hgene | CHRNB2 | C0743002 | Abnormal Deep Tendon Reflex | 1 | CTD_human |
Hgene | CHRNB2 | C0750900 | Alzheimer's Disease, Focal Onset | 1 | CTD_human |
Hgene | CHRNB2 | C0750901 | Alzheimer Disease, Early Onset | 1 | CTD_human |
Hgene | CHRNB2 | C0751468 | Bulbocavernosus Reflex, Decreased | 1 | CTD_human |
Hgene | CHRNB2 | C0751469 | Bulbocavernousus Reflex Absent | 1 | CTD_human |
Hgene | CHRNB2 | C0751470 | Palmo-Mental Reflex | 1 | CTD_human |
Hgene | CHRNB2 | C0751471 | Reflex, Anal, Decreased | 1 | CTD_human |
Hgene | CHRNB2 | C0751472 | Reflex, Ankle, Abnormal | 1 | CTD_human |
Hgene | CHRNB2 | C0751473 | Reflex, Ankle, Decreased | 1 | CTD_human |
Hgene | CHRNB2 | C0751474 | Reflex, Biceps, Abnormal | 1 | CTD_human |
Hgene | CHRNB2 | C0751475 | Reflex, Biceps, Decreased | 1 | CTD_human |
Hgene | CHRNB2 | C0751476 | Reflex, Gag, Decreased | 1 | CTD_human |
Hgene | CHRNB2 | C0751477 | Reflex, Knee, Abnormal | 1 | CTD_human |
Hgene | CHRNB2 | C0751478 | Reflex, Knee, Decreased | 1 | CTD_human |
Hgene | CHRNB2 | C0751479 | Reflex, Moro, Asymmetric | 1 | CTD_human |
Hgene | CHRNB2 | C0751480 | Reflex, Triceps, Abnormal | 1 | CTD_human |
Hgene | CHRNB2 | C0751481 | Reflex, Triceps, Decreased | 1 | CTD_human |
Hgene | CHRNB2 | C0751508 | Long Sleeper Syndrome | 1 | CTD_human |
Hgene | CHRNB2 | C0751509 | Short Sleeper Syndrome | 1 | CTD_human |
Hgene | CHRNB2 | C0751510 | Sleep-Related Neurogenic Tachypnea | 1 | CTD_human |
Hgene | CHRNB2 | C0751511 | Subwakefullness Syndrome | 1 | CTD_human |
Hgene | CHRNB2 | C0751642 | Epilepsy, Anterior Fronto-Polar | 1 | CTD_human |
Hgene | CHRNB2 | C0751643 | Epilepsy, Orbito-Frontal | 1 | CTD_human |
Hgene | CHRNB2 | C0851578 | Sleep Disorders | 1 | CTD_human |
Hgene | CHRNB2 | C1263846 | Attention deficit hyperactivity disorder | 1 | CTD_human |
Hgene | CHRNB2 | C1279420 | Anxiety neurosis (finding) | 1 | CTD_human |
Hgene | CHRNB2 | C1321905 | Minimal Brain Dysfunction | 1 | CTD_human |
Hgene | CHRNB2 | C3696898 | Autosomal Dominant Nocturnal Frontal Lobe Epilepsy | 1 | ORPHANET |
Hgene | CHRNB2 | C4042891 | Sleep Wake Disorders | 1 | CTD_human |